AMR
(Antimicrobial Resistance)
AMR remains one of the greatest challenges today for the safe provision of healthcare and infection prevention & control, with superbugs threatening our ability to treat common infectious diseases. The COVID-19 pandemic has further elevated concerns about AMR, with surges in antibiotic prescribing, hospitalisations and drug-resistant bacterial transmissions.1
It is estimated that in the year 2050, 10 million people could die annually because of drug-resistant infections.
– World Health Organization2
Protect Patients & Fight AMR with Fast PCR in ~1 Hour*
On-demand PCR with the GeneXpert® system greatly improves time to result, allowing healthcare professionals to quickly identify, isolate and appropriately manage patients, helping prevent the spread.3 Explore more in a short film produced for Cepheid by BBC StoryWorks Commercial Productions.
* Turnaround times vary by test. See individual Product Inserts for specific turnaround times.
1 Langford B, et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect. 2020 Dec;26(12):1622-1629.
2 World Health Organization (WHO). 2019. New report calls for urgent action to avert antimicrobial resistance crisis. Accessed March 2021. https://www.who.int/news/item/29-04-2019-new-report-calls-for-urgent-action-to-avert-antimicrobial-resistance-crisis
3 Corless C, et al. Impact of different carbapenemase-producing Enterobacterales screening strategies in a hospital setting. IPIP. 2020 May;3(2):100011.
© 2022-2023 Cepheid.